A controlled trial of dipyridamole in human renal transplantation and an assessment of platelet function studies in rejection.
D001706:Biopsy; D001779:Blood Coagulation Factors / Q000032:analysis; D001792:Blood Platelets / Q000502:physiology*; D002118:Calcium / Q000097:blood; D002470:Cell Survival; D002860:Chromium Radioisotopes; D002986:Clinical Trials as Topic; D004176:Dipyridamole / Q000097:blood / Q000627:therapeutic use*; D006084:Graft Rejection / Q000187:drug effects*; D006207:Half-Life; D006650:Histocompatibility Testing; D006801:Humans; D007668:Kidney / Q000000981:diagnostic imaging / Q000473:pathology / Q000503:physiopathology; D016030:Kidney Transplantation; D010919:Placebos; D010973:Platelet Adhesiveness; D011241:Prednisone / Q000627:therapeutic use; D011859:Radiography; D012077:Renal Artery / Q000000981:diagnostic imaging; D013925:Thromboplastin / Q000097:blood; D014184:Transplantation, Homologous
D001779:Blood Coagulation Factors; D002860:Chromium Radioisotopes; D010919:Placebos; D004176:Dipyridamole; D013925:Thromboplastin; D002118:Calcium; D011241:Prednisone